淋巴瘤CAR-T细胞治疗中的瘤微环境
Yuchen Zhu1, Kailin Xu2, Ying Wang2
1Blood Diseases Institute, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, China.
Best practice & research. Clinical haematology
|July 23, 2025
概括
化学抗原受体 (CAR) -T细胞疗法对淋巴瘤有希望,但面临挑战. 向瘤微环境 (TME) 可能克服耐药性并提高CAR-T细胞的有效性,从而改善患者的治疗结果.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法是一种革命性的治疗复发性或耐火性淋巴瘤.
- 尽管成功,但在一些患者中发生治疗耐药性和早期复发.
- 淋巴瘤瘤微环境 (TME) 显著影响CAR-T细胞的疗效.
研究的目的:
- 审查淋巴瘤TME对CAR-T细胞功能的影响.
- 讨论针对TME组件的策略,以改善CAR-T细胞治疗.
主要方法:
- 对研究CAR-T细胞治疗和淋巴瘤TME的研究进行文献综述.
- 分析TME成分如何影响CAR-T细胞持久性,活性和细胞毒性.
主要成果:
- 输入CAR-T细胞会改变TME,影响内源性免疫反应.
- TME成分极大地影响CAR-T细胞功能,构成有效性的障碍.
- 特定的TME特征可以阻碍CAR-T细胞的持久性和细胞毒性活动.
结论:
- 淋巴瘤TME是影响CAR-T细胞治疗结果的关键因素.
- 针对TME提供了一种有希望的策略,以克服耐药性并提高CAR-T细胞的有效性.
- 对TME调节的进一步研究对于优化淋巴瘤中CAR-T细胞治疗至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662